Biosynex SA completed the acquisition of 40% stakes in Theradiag SA.
Biosynex SA (ENXTPA:ALBIO) completed the acquisition of 40% stakes in Theradiag SA (ENXTPA:ALTER) on January 12, 2023. The offer will be reopened for a period of at least 10 trading days for remaining stake.